Cargando…
FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML) associated with poor prognosis. We previously reported that activation of STAT5 confers resistance to PI3K/Akt inhibitors on the FLT3-ITD-positive AML cell line MV4-11 and 32D cells driven by FLT3-ITD (32D/ITD) bu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823622/ https://www.ncbi.nlm.nih.gov/pubmed/29507660 http://dx.doi.org/10.18632/oncotarget.22926 |
_version_ | 1783301910305964032 |
---|---|
author | Okada, Keigo Nogami, Ayako Ishida, Shinya Akiyama, Hiroki Chen, Cheng Umezawa, Yoshihiro Miura, Osamu |
author_facet | Okada, Keigo Nogami, Ayako Ishida, Shinya Akiyama, Hiroki Chen, Cheng Umezawa, Yoshihiro Miura, Osamu |
author_sort | Okada, Keigo |
collection | PubMed |
description | FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML) associated with poor prognosis. We previously reported that activation of STAT5 confers resistance to PI3K/Akt inhibitors on the FLT3-ITD-positive AML cell line MV4-11 and 32D cells driven by FLT3-ITD (32D/ITD) but not by FLT3 mutated in the tyrosine kinase domain (32D/TKD). Here, we report the involvement of Pim kinases expressed through STAT5 activation in acquisition of this resistance. The specific pan-Pim kinase inhibitor AZD1208 as well as PIM447 in combination with the PI3K inhibitor GDC-0941 or the Akt inhibitor MK-2206 cooperatively downregulated the mTORC1/4EBP1 pathway, formation of the eIF4E/eIF4G complex, and Mcl-1 expression leading to activation of Bak and Bax to induce caspase-dependent apoptosis synergistically in these cells. These cooperative effects were enhanced or inhibited by knock down of mTOR or expression of its activated mutant, respectively. Overexpression of Mcl-1 conferred the resistance on 32D/ITD cells to combined inhibition of the PI3K/Akt pathway and Pim kinases, while the Mcl-1-specific BH3 mimetic A-1210477 conquered the resistance of MV4-11 cells to GDC-0941. Furthermore, overexpression of Pim-1 in 32D/TKD enhanced the mTORC1/Mcl-1 pathway and partially protected it from the PI3K/Akt inhibitors or the FLT3 inhibitor gilteritinib to confer the resistance to PI3K/Akt inhibitors. Finally, AZD1208 and GDC-0941 cooperatively inhibited the mTORC1/Mcl-1 pathway and reduced viable cell numbers of primary AML cells from some FLT3-ITD positive cases. Thus, Pim kinases may protect the mTORC1/4EBP1/Mcl-1 pathway to confer the resistance to the PI3K/Akt inhibitors on FLT3-ITD cells and represent promising therapeutic targets. |
format | Online Article Text |
id | pubmed-5823622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-58236222018-03-05 FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway Okada, Keigo Nogami, Ayako Ishida, Shinya Akiyama, Hiroki Chen, Cheng Umezawa, Yoshihiro Miura, Osamu Oncotarget Research Paper FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML) associated with poor prognosis. We previously reported that activation of STAT5 confers resistance to PI3K/Akt inhibitors on the FLT3-ITD-positive AML cell line MV4-11 and 32D cells driven by FLT3-ITD (32D/ITD) but not by FLT3 mutated in the tyrosine kinase domain (32D/TKD). Here, we report the involvement of Pim kinases expressed through STAT5 activation in acquisition of this resistance. The specific pan-Pim kinase inhibitor AZD1208 as well as PIM447 in combination with the PI3K inhibitor GDC-0941 or the Akt inhibitor MK-2206 cooperatively downregulated the mTORC1/4EBP1 pathway, formation of the eIF4E/eIF4G complex, and Mcl-1 expression leading to activation of Bak and Bax to induce caspase-dependent apoptosis synergistically in these cells. These cooperative effects were enhanced or inhibited by knock down of mTOR or expression of its activated mutant, respectively. Overexpression of Mcl-1 conferred the resistance on 32D/ITD cells to combined inhibition of the PI3K/Akt pathway and Pim kinases, while the Mcl-1-specific BH3 mimetic A-1210477 conquered the resistance of MV4-11 cells to GDC-0941. Furthermore, overexpression of Pim-1 in 32D/TKD enhanced the mTORC1/Mcl-1 pathway and partially protected it from the PI3K/Akt inhibitors or the FLT3 inhibitor gilteritinib to confer the resistance to PI3K/Akt inhibitors. Finally, AZD1208 and GDC-0941 cooperatively inhibited the mTORC1/Mcl-1 pathway and reduced viable cell numbers of primary AML cells from some FLT3-ITD positive cases. Thus, Pim kinases may protect the mTORC1/4EBP1/Mcl-1 pathway to confer the resistance to the PI3K/Akt inhibitors on FLT3-ITD cells and represent promising therapeutic targets. Impact Journals LLC 2017-12-04 /pmc/articles/PMC5823622/ /pubmed/29507660 http://dx.doi.org/10.18632/oncotarget.22926 Text en Copyright: © 2018 Okada et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Okada, Keigo Nogami, Ayako Ishida, Shinya Akiyama, Hiroki Chen, Cheng Umezawa, Yoshihiro Miura, Osamu FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway |
title | FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway |
title_full | FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway |
title_fullStr | FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway |
title_full_unstemmed | FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway |
title_short | FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway |
title_sort | flt3-itd induces expression of pim kinases through stat5 to confer resistance to the pi3k/akt pathway inhibitors on leukemic cells by enhancing the mtorc1/mcl-1 pathway |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823622/ https://www.ncbi.nlm.nih.gov/pubmed/29507660 http://dx.doi.org/10.18632/oncotarget.22926 |
work_keys_str_mv | AT okadakeigo flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway AT nogamiayako flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway AT ishidashinya flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway AT akiyamahiroki flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway AT chencheng flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway AT umezawayoshihiro flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway AT miuraosamu flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway |